Prognostic value of DAXX/ATRX loss of expression and ALT activation in PanNETs: is it time for clinical implementation?
- PMID: 33975869
- PMCID: PMC8995811
- DOI: 10.1136/gutjnl-2021-324664
Prognostic value of DAXX/ATRX loss of expression and ALT activation in PanNETs: is it time for clinical implementation?
Keywords: neuroendocrine cells; neuroendocrine tumors; pancreatic endocrine tumour; pancreatic islet cell.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size.Gut. 2022 May;71(5):961-973. doi: 10.1136/gutjnl-2020-322595. Epub 2021 Apr 13. Gut. 2022. PMID: 33849943 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical